H9 Cells (derivative of HuT 78)

The H9 cell line, derived from a clonal derivative of the HUT 78 T-cell line from an adult patient with Sezary syndrome, exhibits specific clinical characteristics making it highly relevant in HIV research. It is notably permissive for HIV-1 replication, facilitating the isolation and propagation of HIV-1 from the blood of patients with AIDS and pre-AIDS conditions. This feature underscores its utility in studying viral behaviors and testing antiviral strategies under varied clinical scenarios.
Karyotypically, H9 is near triploid with a modal chromosome number of 69, ranging from 58 to 74, and exhibits a 2.5% frequency of higher ploidies. The cell line displays an extremely complex karyotype, with nearly 60% of the chromosomes per cell consisting of structurally altered marker chromosomes, including translocations such as t(3p4q), t(5q6q), t(5p6p), and deletions like del(7)(q32). Such chromosomal abnormalities contribute to the line’s unique genetic profile, influencing its behavior and response to viral infections. The absence of normal chromosomes N4, N5, N6, N7, N10, N13, N18, N19, N20, and X further distinguishes its genetic makeup.
Moreover, the H9 cell line is tumorigenic in nature, demonstrated by successful subcutaneous tumor formation in nude mice when inoculated with 10(7) cells. It expresses a range of antigens including CD4 and various human leukocyte antigens (HLA) like A1, B62, C3, DR4, and DQ3, which play critical roles in immune recognition and response. Its susceptibility to HIV-1 and expression of genes like interleukin-2 (IL-2) are pivotal for investigating immune responses and viral interactions, making H9 a vital tool in the landscape of immunological and virological research.